Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Fresenius Medical Care AG & Co. KGaA (GB:0H9X)
LSE:0H9X
Holding GB:0H9X?
Track your performance easily
0H9X Analyst Ratings
Hold
3 Buy
9 Hold
4 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0H9X Stock 12 Month Forecast
Average Price Target
€46.19
▼(-2.68% Downside)
| Highest Price Target€78.00 | Average Price Target€46.19 | Lowest Price Target€33.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Berenberg Bank
Reiterated
01/30/25
Bernstein
Reiterated
01/29/25
Citi
Reiterated
01/28/25
Deutsche Bank
Reiterated
01/28/25
Bank of America Securities
Reiterated
01/27/25
J.P. Morgan
Reiterated
01/23/25
Goldman Sachs
Reiterated
01/21/25
Kepler Capital
Reiterated
01/21/25
Jefferies
Reiterated
01/15/25
Morgan Stanley
Reiterated
01/06/25
Unknown Analyst
Not Ranked
DZ BANK AG
―
Hold
―
Reiterated
12/27/24
Warburg Research
€31→€36
Sell
-24.15%
Downside
Reiterated
12/17/24
Warburg Research Reaffirms Their Sell Rating on Fresenius Medical Care AG & Co. KGaA (0H9X)
HSBC
€37→€48
Buy
1.14%
Upside
Upgraded
12/04/24
HSBC Upgrades Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) to BuyHSBC analyst Sezgi Oezener upgraded Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) from Hold to Buy with a price target of EUR48.00 (from EUR37.00).
UBS
€39
Hold
-17.83%
Downside
Reiterated
11/26/24
UBS Remains a Hold on Fresenius Medical Care AG & Co. KGaA (0H9X)
Barclays
€39→€41
Hold
-13.61%
Downside
Reiterated
11/21/24
Fresenius Medical Care AG #x26; Co KGaA (FME:GR) (FMS) PT Raised to EUR41 at BarclaysBarclays analyst Hassan Al-Wakeel raised the price target on Fresenius Medical Care AG Co KGaA (FME:GR) (NYSE: FMS) to EUR41.00 (from EUR39.00) while maintaining a Equalweight rating.
Best Analysts Covering Fresenius Medical Care AG & Co. KGaA
Which Analyst Should I Follow If I Want to Buy GB:0H9X and Sell After:
1 Month
xxx
Success Rate
13/20 ratings generated profit
Average Return
+3.32%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 65.00% of your transactions generating a profit, with an average return of +3.32% per trade.
3 Months
xxx
Success Rate
17/20 ratings generated profit
Average Return
+8.25%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 85.00% of your transactions generating a profit, with an average return of +8.25% per trade.
1 Year
Success Rate
16/20 ratings generated profit
Average Return
+14.85%
reiterated a buy rating yesterday
Copying Victoria Lambert's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +14.85% per trade.
2 Years
xxx
Success Rate
20/20 ratings generated profit
Average Return
+28.27%
reiterated a xxx
rating yesterday
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +28.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0H9X Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
0
0
0
0
0
Buy
5
2
5
7
8
Hold
7
2
12
17
21
Sell
11
12
13
13
10
Strong Sell
0
0
0
0
0
total
23
16
30
37
39
Each month's total comprises the sum of three months' worth of ratings.
0H9X Financial Forecast
0H9X Stock Forecast FAQ
What is GB:0H9X’s average 12-month price target, according to analysts?
Based on analyst ratings, Fresenius Medical Care AG & Co. KGaA’s 12-month average price target is €46.19.
What is GB:0H9X’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0H9X, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Fresenius Medical Care AG & Co. KGaA a Buy, Sell or Hold?
Fresenius Medical Care AG & Co. KGaA has a consensus rating of Hold, which is based on 3 buy ratings, 9 hold ratings and 4 sell ratings.
What is Fresenius Medical Care AG & Co. KGaA’s share price target?
The average share price target for Fresenius Medical Care AG & Co. KGaA is €46.19. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €78.00 ,and the lowest forecast is €33.00. The average share price target represents -2.68% Decrease from the current price of €47.46.
The highest analyst share price target is €78.00 ,and the lowest forecast is €33.00. The average share price target represents -2.68% Decrease from the current price of €47.46.
What do analysts say about Fresenius Medical Care AG & Co. KGaA?
Fresenius Medical Care AG & Co. KGaA’s analyst rating consensus is a Hold. This is based on the ratings of 16 Wall Streets Analysts.
How can I buy shares of Fresenius Medical Care AG & Co. KGaA?
To buy shares of GB:0H9X, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.